Abstract | OBJECTIVES: PATIENTS AND METHODS: We studied 152 spondyloarthritis (SpA) patients: 69 PsA, 61 AS, 22 SAPHO, and 29 controls. We recorded age, sex, disease duration, and treatment. We assessed BASDAI, VAS, and PASI scores. Serum IL-6, IL-23, VEGF, EGF, FGFb, and FGFa levels were determined using ELISA. We estimated ESR and CRP. RESULTS: Serum IL-6 and IL-23 levels were higher in SpA than in control (P < 0.00001 and P = 0.0004, resp.). There was a positive correlation between serum IL-6 and CRP in AS (P = 0.000001), PsA (P = 0.000001), and SAPHO (P = 0.0003) patients. There was a positive correlation between serum IL-6 and ESR in AS (P = 0.000001), PsA (P = 0.002), and SAPHO (P = 0.02) patients. There was no correlation of serum IL-6 and IL-23 with VAS, BASDAI, and angiogenic cytokines in SpA. CONCLUSIONS: Serum IL-6 but not serum IL-23 correlated with ESR and CRP in SpA. No correlation was found of serum IL-6 and IL-23 with VAS, BASDAI, and angiogenic cytokines.
|
Authors | Hanna Przepiera-Będzak, Katarzyna Fischer, Marek Brzosko |
Journal | Mediators of inflammation
(Mediators Inflamm)
Vol. 2015
Pg. 785705
( 2015)
ISSN: 1466-1861 [Electronic] United States |
PMID | 26339141
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytokines
- IL6 protein, human
- Interleukin-23
- Interleukin-6
- Vascular Endothelial Growth Factor A
- Fibroblast Growth Factors
- Epidermal Growth Factor
|
Topics |
- Acquired Hyperostosis Syndrome
(blood)
- Adult
- Arthritis, Psoriatic
(blood)
- Cytokines
(blood)
- Epidermal Growth Factor
(blood)
- Female
- Fibroblast Growth Factors
(blood)
- Humans
- Interleukin-23
(blood)
- Interleukin-6
(blood)
- Male
- Middle Aged
- Spondylitis, Ankylosing
(blood)
- Vascular Endothelial Growth Factor A
(blood)
|